Loading...
Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis
Hyperlipidemic pancreatitis (HP) is a serious inflammatory disease with very high mortality and multiple organ injuries including renal injury. Rosiglitazone (Ros), an agonist of peroxisome proliferator activated receptor-γ (PPAR-γ), was reported to show a protective role against pancreatitis. Howev...
Na minha lista:
| Udgivet i: | Int J Clin Exp Pathol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4502997/ https://ncbi.nlm.nih.gov/pubmed/26191125 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|